SB402 (2024) Detail

(New Title) relative to allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.


SB 402 - AS AMENDED BY THE SENATE

 

03/07/2024   0825s

2024 SESSION

24-2961

11/05

 

SENATE BILL 402

 

AN ACT relative to allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.

 

SPONSORS: Sen. Birdsell, Dist 19

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill allows pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/07/2024   0825s 24-2961

11/05

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT relative to allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Pharmacist Administration of Vaccines.  Amend the introductory paragraph of RSA 318:16-b to read as follows:

A pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the general public, [A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer haemophilus influenza, hepatitis A, hepatitis B, hepatitis A and B, human papillomavirus, meningococcal, pneumococcal, tetanus and diphtheria, varicella, zoster, RSV (respiratory syncytial virus), MMR (measles, mumps, and rubella), and Tdap (tetanus, diphtheria and pertussis) vaccines, which have been approved by the Food and Drug Administration] and vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, or successor organization, to individuals 18 years of age or older as ordered by an immunizing pharmacist.  The pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician shall:

2  Effective Date.  This act shall take effect 60 days after its passage.

Amendments

Date Amendment
Feb. 21, 2024 2024-0825s

Links


Date Body Type
Feb. 14, 2024 Senate Hearing
Feb. 14, 2024 Senate Hearing
March 7, 2024 Senate Floor Vote
March 7, 2024 Senate Floor Vote
April 25, 2024 House Hearing

Bill Text Revisions

SB402 Revision: 41137 Date: March 7, 2024, 12:01 p.m.
SB402 Revision: 40970 Date: Feb. 21, 2024, 4:10 p.m.
SB402 Revision: 40237 Date: Dec. 12, 2023, 3:02 p.m.

Docket


April 17, 2024: Public Hearing: 04/25/2024 01:45 pm LOB 203


March 12, 2024: Introduced 03/11/2024 and referred to Health, Human Services and Elderly Affairs


March 7, 2024: Ought to Pass with Amendment 2024-0825s, MA, VV; OT3rdg; 03/07/2024; SJ 6


Feb. 21, 2024: Committee Report: Ought to Pass with Amendment # 2024-0825s, 03/07/2024; Vote 5-0; CC; SC 9


March 7, 2024: Committee Amendment # 2024-0825s, AA, VV; 03/07/2024; SJ 6


Feb. 21, 2024: Committee Report: Ought to Pass with Amendment # 2024-0825s, 03/07/2024; Vote 5-0; CC; SC 9


March 7, 2024: Committee Amendment # 2024-0825s, AA, VV; 03/07/2024; SJ 6


Feb. 8, 2024: Hearing: 02/14/2024, Room 101, LOB, 10:00 am; SC 7


Feb. 12, 2024: ==ROOM CHANGE== Hearing: 02/14/2024, Room 100, SH, 10:00 am; ; SC 7


Dec. 12, 2023: To Be Introduced 01/03/2024 and Referred to Health and Human Services; SJ 1